In The News Posted December 23, 2020 Share Posted December 23, 2020 SEOUL, South Korea, Dec. 22, 2020 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ symbol: 048410) announced on the 23rd, December 2020, that CNPharm, its major shareholding bio tech company, has succeeded in developing 'Poly-COV01,' an injection drug for the potential treatment of patients...View the full article Quote Link to comment Share on other sites More sharing options...
Recommended Posts